openPR Logo
Press release

Deadline on May 5th coming up in Lawsuit for Investors in Tilray, Inc. (NASDAQ: TLRY)

04-20-2020 07:37 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on May 5, 2020 in the lawsuit for certain investors in Tilray, Inc. (NASDAQ: TLRY).

A Deadline is coming up on May 5, 2020 in the lawsuit for certain investors in Tilray, Inc. (NASDAQ: TLRY).

A deadline is coming up on May 5, 2020 in the lawsuit filed for certain investors of Tilray, Inc. (NASDAQ: TLRY) over alleged securities laws violations by Tilray, Inc.

Investors who purchased shares of Tilray, Inc. (NASDAQ: TLRY) have certain options and there are strict and short deadlines running. Deadline: May 5, 2020. NASDAQ: TLRY stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Eastern District of New York the plaintiff alleges on behalf of purchasers of Tilray, Inc. (NASDAQ: TLRY) common shares between January 15, 2019 and March 2, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between January 15, 2019 and March 2, 2020, the defendants made false and/or misleading statements and/or failed to disclose that the purported advantages of the ABG Agreement were significantly overstated, that the underperformance of the ABG Agreement would foreseeably have a significant impact on the Company's financial results, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Tilray, Inc. (NASDAQ: TLRY) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on May 5th coming up in Lawsuit for Investors in Tilray, Inc. (NASDAQ: TLRY) here

News-ID: 2017583 • Views: 396

More Releases from Shareholders Foundation

ProShares Ultra Bloomberg Crude Oil (NYSEArca: UCO) Investor Alert: Deadline in …
A deadline is coming up on September 28, 2020 in the lawsuit filed for certain investors of ProShares Ultra Bloomberg Crude Oil (NYSEArca: UCO) over alleged securities laws violations. Investors who purchased shares of ProShares Ultra Bloomberg Crude Oil (NYSEArca: UCO) have certain options and there are strict and short deadlines running. Deadline: September 28, 2020. NYSEArca: UCO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Long-Term Investors in shares of Forescout Technolog …
An investigation was announced for long-term investors in shares of Forescout Technologies, Inc. (NASDAQ: FSCT) concerning potential breaches of fiduciary duties by certain directors and officers of Forescout Technologies, Inc.. Investors who are current long term investors in Forescout Technologies, Inc. (NASDAQ: FSCT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in NASDAQ:
Investigation announced for Long-Term Investors in shares of Hebron Technology C …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Hebron Technology Co., Ltd.. Investors who are current long term investors in Hebron Technology Co., Ltd. (NASDAQ: HEBT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: HEBT stocks follows a lawsuit filed against Hebron
Investigation announced for Investors in shares of CrossFirst Bankshares, Inc. ( …
An investigation was announced concerning potential securities laws violations by CrossFirst Bankshares, Inc. in connection with certain financial statements. Investors who purchased shares of CrossFirst Bankshares, Inc. (NASDAQ: CFB), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether certain statements by CrossFirst Bankshares, Inc. regarding its business, its prospects and its operations were materially false

All 5 Releases


More Releases for Tilray

Medical Cannabis Market - Dynamic Business Environment during 2018 – 2026: BOL …
Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. The various economies are involved in the activities to legalize the export of medicinal cannabis product, which
Medical Cannabis Market Demands and Growth Prediction 2018 to 2025 | Leading Ven …
Coherent Market Insights has announced the addition of the “Medical Cannabis Market, by Point of Sale, Active Ingredient, and Therapeutic Application - Global Trends, and Forecast to 2025”. The report classifies the Medical Cannabis Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or
Medical Cannabis Market 2026: Growth And Revenue Analysis | BOL Pharma, Tilray, …
Medicinal cannabis are also known as Medical marijuana, which area used either to treat disease or to improve their symptoms. The two cannabinoids - delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) are used in treatment of certain disease or health conditions such as pain, blood pressure, memory, concentration, appetite, sensory stimulus, muscular problems, and seizures. The various economies are involved in the activities to legalize the export of medicinal cannabis product, which
Incredible Growth Of Medical Cannabis Market 2026 Growing With Major Eminent Key …
According to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users. Such a large user base makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding legalization of the drug for medicinal use. The National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat numerous diseases and conditions such as autoimmune disease, pain,
AB InBev enters the cannabis industry in partnership with Tilray Inc.
Belgium-based multinational brewing company Anheuser-Busch InBev (AB InBev) has reportedly joined the cannabis industry through a research collaboration with Tilray Inc., a pharmaceutical and cannabis company based in Canada. As per reliable sources, the two companies will conduct a collaborative research into cannabis-infused, non-alcoholic beverages. Each company will make up to 50 million-dollar investment in the partnership that is limited to Canada. Decisions on commercialization will be made once marijuana beverages
Medical Cannabis Market Report for Period 2017 till 2025 BOL Pharma, Tilray, Med …
Coherent Market Insights has announced the addition of the “Medical Cannabis Market Size Status and Forecast 2025”, The report classifies the global Medical Cannabis Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Medical Cannabis Speaker market, analyzes and researches the Medical Cannabis Speaker development status and forecast in North America, Europe, Asia